Targeting major vault protein in senescence-associated apoptosis resistance

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 4, 2009, Pages 479-484

  Sung, Jin Ryu ^a   Sang, Chul Park ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Fibroblast; MVP; Senescence; Survival

Indexed keywords

LUNG RESISTANCE PROTEIN; ANTINEOPLASTIC AGENT; RIBONUCLEOPROTEIN; TUMOR PROTEIN;

AGING; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; DIPLOIDY; FIBROBLAST; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; CELL AGING; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; ONCOGENE; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE;

AGING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL AGING; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, JUN; HUMANS; MICE; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 67649215113     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220902832705     Document Type: Review

References (62)

1. van Zon A, Mossink MH, Scheper RJ, et al. The vault complex. Cell Mol Life Sci 2003;60:1828-1837 (Pubitemid 37222581)
2. Hu Y, Stephen AG, Cao J, et al. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Int J Cancer 2002;97:149-156 (Pubitemid 34019948)
3. Kickhoefer VA, Rajavel KS, Scheffer GL, et al. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 1998;273:8971-8974 (Pubitemid 28176182)
4. Schroeijers AB, Siva AC, Scheffer GL, et al. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res 2000;60:1104-1110 (Pubitemid 30129552)
5. Mossink MH, van Zon A, Franzel-Luiten E, et al. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. Cancer Res 2002;62:7298-7304 (Pubitemid 36025253)
6. Mossink MH, de Groot J, van Zon A, et al. Unimpaired dendritic cell functions in MVP/LRP knockout mice. Immunology 2003;110:58-65 (Pubitemid 37059672)
7. van Zon A, Mossink MH, Schoester M, et al. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer Res 2004;64:4887-4892 (Pubitemid 38924533)
8. Schroeijers AB, Reurs AW, Scheffer GL, et al. Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol 2002;168:1572-1578 (Pubitemid 34135751)
9. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, et al. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 2007;317:130-132 • This paper provides evidence of a role for MVP in innate immunity to lung pathogens. (Pubitemid 47056473)
10. Mrazek J, Kreutmayer SB, Grasser FA, et al. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007;35:e73. Published online on May 3, 2007 doi:10.1093/nar/gkm244 (Pubitemid 47073615)
11. Kolli S, Zito CI, Mossink MH, et al. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 2004;279:29374-29385 •• This paper provides evidence of a functional role for MVP in cell survival. (Pubitemid 38915816)
12. Yu Z, Fotouhi-Ardakani N, Wu L, et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem 2002;277:40247-40252 (Pubitemid 35215595)
13. Kim E, Lee S, Mian MF, et al. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. FEBS J 2006;273:793-804 • In this paper it isdemonstrated that MVP is involved in the regulation of Src function and cell growth.
14. Vasu SK, Rome LH. Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein. J Biol Chem 1995;270:16588-16594
15. MacFarlane M, Williams AC. Apoptosis and disease: a life or death decision. EMBO Rep 2004;5:674-678
16. Yeo EJ, Hwang YC, Kang CM, et al. Reduction of UV-induced cell death in the human senescent fibroblasts. Mol Cells 2000;10:415-422
17. Ryu SJ, Cho KA, Oh YS, Park SC. Role of Src-specific phosphorylation site on focal adhesion kinase for senescence-associated apoptosis resistance. Apoptosis 2006;11:303-313
18. Sakurai N, Utsumi T. Posttranslational N-myristoylation is required for the anti-apoptotic activity of human tGelsolin, the C-terminal caspase cleavage product of human gelsolin. J Biol Chem 2006;281:14288-14295 (Pubitemid 43848357)
19. Hampel B, Malisan F, Niederegger H, et al. Differential regulation of apoptotic cell death in senescent human cells. Exp Gerontol 2004;39:1713-1721 (Pubitemid 39576141)
20. Ryu SJ, Oh YS, Park SC. Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts. Cell Death Differ 2007;14:1020-1028 • This paper presents results showing that senescent HDFs resist apoptosis, induced by three distinct stimuli. (Pubitemid 46629840)
21. Naderi J, Hung M, Pandey S. Oxidative stress-induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and over-expression of Bax: resistance of quiescent cells to oxidative stress. Apoptosis 2003;8:91-100 (Pubitemid 36133142)
22. Huang Y, Corbley MJ, Tang Z, et al. Down-regulation of p21WAF1 promotes apoptosis in senescent human fibroblasts: involvement of retinoblastoma protein phosphorylation and delay of cellular aging. J Cell Physiol 2004;201:483-491 (Pubitemid 39453133)
23. Hampel B, Wagner M, Teis D, et al. Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 2005;4:325-330 (Pubitemid 43918282)
24. Ahn JS, Jang IS, Rhim JH, et al. Gelsolin for senescence-associated resistance to apoptosis. Ann NY Acad Sci 2003;1010:493-495 (Pubitemid 38265032)
25. Ryu SJ, An HJ, Oh YS, et al. On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis. Cell Death Differ 2008;15:1673-1680 •• This paper presnts results indicating that MVP is important in the resistance of senescent HDFs to apoptosis.
26. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol 1986;103:699-709 (Pubitemid 17177322)
27. Rome L, Kedersha N, Chugani D. Unlocking vaults: organelles in search of a function. Trends Cell Biol 1991;1:47-50 (Pubitemid 121002487)
28. Kedersha NL, Heuser JE, Chugani DC, Rome LH. Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol 1991;112:225-235 (Pubitemid 21909613)
29. Kedersha NL, Miquel MC, Bittner D, Rome LH. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 1990;110:895-901 (Pubitemid 20136467)
30. van Zon A, Mossink MH, Schoester M, et al. Structural domains of vault proteins: a role for the coiled coil domain in vault assembly. Biochem Biophys Res Commun 2002;291:535-541 (Pubitemid 34687377)
31. Zheng CL, Sumizawa T, Che XF, et al. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochem Biophys Res Commun 2005;326:100-107
32. Scheffer GL, Schroeijers AB, Izquierdo MA, et al. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol 2000;12:550-556 (Pubitemid 32039654)
33. Berger W, Elbling L, Micksche M. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int J Cancer 2000;88:293-300 (Pubitemid 30745226)
34. Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer 1997;72:1021-1026 (Pubitemid 27433568)
35. Berger W, Spiegl-Kreinecker S, Buchroithner J, et al. Overexpression of the human major vault protein in astrocytic brain tumor cells. Int J Cancer 2001;94:377-382 (Pubitemid 32906068)
36. Zurita AJ, Diestra JE, Condom E, et al. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. Br J Cancer 2003;88:879-886 (Pubitemid 36520875)
37. Stein U, Jurchott K, Schlafke M, Hohenberger P. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients. J Clin Oncol 2002;20:3282-3292 (Pubitemid 34831527)
38. Komarov PG, Shtil AA, Holian O, et al. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol Res 1998;10:185-192 (Pubitemid 128736314)
39. Steiner E, Holzmann K, Pirker C, et al. SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. Biochem Biophys Res Commun 2004;317:235-243 (Pubitemid 38401990)
40. Steiner E, Holzmann K, Pirker C, et al. The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals. J Cell Sci 2006;119:459-469 • This paper provides evidence for a role of MVP in the regulation of IFN-γ-induced gene expression.
41. Stein U, Walther W, Laurencot CM, et al. Tumor necrosis factor-α and expression of the multidrug resistance-associated genes LRP and MRP. J Natl Cancer Inst 1997;89:807-813 (Pubitemid 27242283)
42. Lange C, Walther W, Schwabe H, Stein U. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem Biophys Res Commun 2000;278:125-133 • This paper reports chracterization of DNA sequences upstream of the transcription initiation site of the MVP gene. (Pubitemid 30951610)
43. Kickhoefer VA, Vasu SK, Rome LH. Vaults are the answer, what is the question? Trends Cell Biol 1996;6:174-178
44. Steiner E, Holzmann K, Elbling L, et al. Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 2006;7:923-934 • A research overview summarizing cellular functions of vaults. (Pubitemid 44234394)
45. Herrmann C, Golkaramnay E, Inman E, et al. Recombinant major vault protein is targeted to neuritic tips of PC12 cells. J Cell Biol 1999;144:1163-1172 (Pubitemid 29157296)
46. Hamill DR, Suprenant KA. Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. Dev Biol 1997;190:117-128 (Pubitemid 27444741)
47. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci 1993;106(Pt 1):23-29 (Pubitemid 23286775)
48. Abbondanza C, Rossi V, Roscigno A, et al. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J Cell Biol 1998;141:1301-1310 (Pubitemid 28289906)
49. Berger W, Steiner E, Grusch M, et al. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci 2009;66:43-61 •• A comprehensive review on MVP in intracellular signal transduction and immune defense.
50. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993;53:1475-1479 (Pubitemid 23113213)
51. Scheffer GL, Wijngaard PL, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995;1:578-582
52. Siva AC, Raval-Fernandes S, Stephen AG, et al. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer 2001;92:195-202 (Pubitemid 32225369)
53. Izquierdo MA, Scheffer GL, Flens MJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996;148:877-887 (Pubitemid 126660679)
54. Izquierdo MA, Shoemaker RH, Flens MJ, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996;65:230-237 (Pubitemid 26051685)
55. Ohno N, Tani A, Uozumi K, et al. Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia. Blood 2001;98:1160-1165
56. Kitazono M, Okumura H, Ikeda R, et al. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Int J Cancer 2001;91:126-131
57. Kitazono M, Sumizawa T, Takebayashi Y, et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 1999;91:1647-1653 (Pubitemid 29479932)
58. Sunnaram BL, Gandemer V, Sebillot M, et al. LRP overexpression in monocytic lineage. Leuk Res 2003;27:755-759 (Pubitemid 36683265)
59. Yi C, Li S, Chen X, et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res 2005;65:5835-5840 • This paper presnts evidence that MVP negatively regulates c-Jun level. (Pubitemid 40911188)
60. Kedersha NL, Hill DF, Kronquist KE, Rome LH. Subpopulations of liver coated vesicles resolved by preparative agarose gel electrophoresis. J Cell Biol 1986;103:287-297 (Pubitemid 16067012)
61. Suprenant KA. Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? Biochemistry 2002;41:14447-14454
62. Izquierdo MA, Scheffer GL, Flens MJ, et al. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 1996;19:191-197 (Pubitemid 26324492)